Enhancing immunogenicity by CpG DNA

Current Opinion in Molecular Therapeutics

Volumn 5, Issue 2, 2003, Pages 180-185

  Jiang, Weiwen ^a   Pisetsky, David S ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Application; CpG oligonucleotides; Immunogenicity; Mechanism

Indexed keywords

BACTERIAL DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; OLIGODEOXYNUCLEOTIDE; RANTES; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELL ACTIVATION; CPG ISLAND; CYTOKINE RELEASE; DRUG MECHANISM; GENE SEQUENCE; GENE STRUCTURE; HELPER CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOSTIMULATION; NATURAL KILLER CELL; NONHUMAN; PROTEIN INTERACTION; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DNA-BINDING PROTEINS; HUMANS; IMMUNITY; OLIGONUCLEOTIDES; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 9;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0038476348     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Tokunaga T, Yamamoto H, Shimada S, Abe H, Fukuda T, Fujisawa Y, Furutani Y, Yano O, Kataoka T, Sudo T: Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst (1984) 72(4):955-962.
2. Messina JP, Gilkeson GS, Pisetsky DS: The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. Cell Immunol (1993) 147(1):148-157.
3. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 374(6522):546-549.
4. Bird AP: CpG-rich islands and the function of DNA methylation. Nature (1986) 321(6067):209-213.
5. Bird AP: CpG islands as gene markers in the vertebrate nucleus. Trends Genet (1987) 3:342-347.
6. Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF: CpG oligodeoxyribonucleotides rescue mature spleen B-cells from spontaneous apoptosis and promote cell cycle entry. J Immunol (1998) 160(12):5898-5906.
7. Hartmann G, Krieg AM: Mechanism and function of a newly identified CpG DNA motif in human primary B-cells. J Immunol (2000) 164(2):944-953.
8. Ballas ZK, Rasmussen WL, Krieg AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol (1996) 157(5):1840-1845.
9. Boggs RT, McGraw K, Condon T, Flournoy S, Villiet P, Bennett CF, Monia BP: Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev (1997) 7(5):461-471.
10. Zhao Q, Yu D, Agrawal S: Site of chemical modifications in CpG containing phosphorothioate oligodeoxynucleotide modulates its immunostimulatory activity. Bioorg Med Chem Lett (1999) 9(24):3453-3458.
11. Yu D, Kandimalla ER, Bhagat L, Tang JY, Cong Y, Tang J, Agrawal S: 'Immunomers' - novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents. Nucleic Acids Res (2002) 30(20):4460-4469.
12. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S: Cutting edge: Role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol (2002) 169(1):10-14.
13. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A: Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor 2. Science (1999) 285(5428):736-739.
14. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ: Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem (1999) 274(25):17406-17409.
15. Opitz B, Schroder NW, Spreitzer I, Michelsen KS, Kirschning CJ, Hallatschek W, Zahringer U, Hartung T, Gobel UB, Schumann RR: Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J Biol Chem (2001) 276(25):22041-22047.
16. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-κB by toll-like receptor 3. Nature (2001) 413(6857):732-738.
17. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M et al: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science (1998) 282(5396):2085-2088.
18. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A: The innate immune response to bacterial flagellin is mediated by toll-like receptor 5. Nature (2001) 410(6832):1099-1103.
19. Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, Takeda K, Akira S: TLR6: A novel member of an expanding toll-like receptor family. Gene (1999) 231(1-2):59-65.
20. Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H, Lipford G, Bauer S: Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol (2002) 3(6):499.
21. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A toll-like receptor recognizes bacterial DNA. Nature (2000) 408(6813):740-745.
22. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA (2001) 98(16):9237-9242.
23. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, Hartmann G: Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol (2001) 31(10):3026-3037.
24. Chuang T, Ulevitch RJ: Identification of hTLR10: A novel human toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta (2001) 1518(1-2):157-161.
25. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol (2002) 168(9):4531-4537.
26. Yi AK, Krieg AM: Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol (1998) 161(9):4493-4497.
27. Yi AK, Tuetken R, Redford T, Waldschmidt M, Kirsch J, Krieg AM: CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol (1998) 160(10):4755-4761.
28. Yi AK, Klinman DM, Martin TL, Matson S, Krieg AM: Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol (1996) 157(12):5394-5402.
29. Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM: CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol (1998) 160(2):870-876.
30. Shirota H, Sano K, Hirasawa N, Terui T, Ohuchi K, Hattori T, Tamura G: B-cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12. J Immunol (2002) 169(2):787-794.
31. Chace JH, Hooker NA, Mildenstein KL, Krieg AM, Cowdery JS: Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol (1997) 84(2):185-193.
32. Stacey KJ, Sweet MJ, Hume DA: Macrophages ingest and are activated by bacterial DNA. J Immunol (1996) 157(5):2116-2122.
33. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC: Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol (1998) 161(6):3042-3049.
34. Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G: Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells. Eur J Immunol (2001) 31(7):2154-2163.
35. Cowdery JS, Chace JH, Yi AK, Krieg AM: Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J Immunol (1996) 156(12):4570-4575.
36. Bendigs S, Salzer U, Lipford GB, Wagner H, Heeg K: CpG-oligodeoxynucleotides co-stimulate primary T-cells in the absence of antigen-presenting cells. Eur J Immunol (1999) 29(4):1209-1218.
37. Myers LP, Krieg AM, Pruett SB: Bacterial DNA does not increase serum corticosterone concentration or prevent increases induced by other stimuli. Int Immunopharmacol (2001) 1(8):1605-1614.
38. Ashwell JD, Lu FW, Vacchio MS: Glucocorticoids in T-cell development and function. Annu Rev Immunol (2000) 18:309-345.
39. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Rocken M, Wagner H, Heeg K: CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol (1998) 160(8):3627-3630.
40. Krieg AM, Love-Homan L, Yi AK, Harty JT: CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol (1998) 161(5):2428-2434.
41. Jorgensen JB, Zou J, Johansen A, Secombes CJ: Immunostimulatory CpG oligodeoxynucleotides stimulate expression of IL-1β and interferon-like cytokines in rainbow trout macrophages via a chloroquine-sensitive mechanism. Fish Shellfish Immunol (2001) 11(8):673-682.
42. Van der Stede Y, Verdonck F, Vancaeneghem S, Cox E, Goddeeris BM: CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. Vet Immunol Immunopathol (2002) 86(1-2):31-41.
43. Verthelyi D, Kenney RT, Seder RA, Gam AA, Friedag B, Klinman DM: CpG oligodeoxynucleotides as vaccine adjuvants in primates. J Immunol (2002) 168(4):1659-1663.
44. Sethi S, Lipford G, Wagner H, Kretzschmar H: Post-exposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet (2002) 360(9328):229-230.
45. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV: CpG oligodeoxynucleotides act as adjuvants that switch on T helper (Th)-1 immunity. J Exp Med (1997) 186(10):1623-1631.
46. Lipford GB, Sparwasser T, Bauer M, Zimmermann S, Koch ES, Heeg K, Wagner H: Immunostimulatory DNA: Sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol (1997) 27(12):3420-3426.
47. Weiner GJ, Liu HM, Wooldridge JE, Dahle CE, Krieg AM: Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci USA (1997) 94(20):10833-10837.
48. Moldoveanu Z, Love-Homan L, Huang WQ, Krieg AM: CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine (1998) 16(11-12):1216-1224.
49. Weeratna RD, McCluskie MJ, Xu Y, Davis HL: CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine (2000) 18(17):1755-1762.
50. Miconnet I, Koenig S, Speiser D, Krieg A, Guillaume P, Cerottini JC, Romero P: CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide. J Immunol (2002) 168(3):1212-1218.
51. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, Krieg AM: Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol (1998) 160(6):2555-2559.
52. Hussain I, Jain VV, Kitagaki K, Businga TR, O'Shaughnessy P, Kline JN: Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides. Laryngoscope (2002) 112(10):1819-1826.
53. Warren TL, Weiner GJ: Synergism between cytosine-guanine oligodeoxynucleotides and monoclonal antibody in the treatment of lymphoma. Semin Oncol (2002) 29(1 Suppl 2):93-97.
54. Wooldridge JE, Ballas Z, Krieg AM, Weiner GJ: Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood (1997) 89(8):2994-2998.
55. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM: Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol (1999) 162(4):2291-2298.
56. Gramzinski RA, Doolan DL, Sedegah M, Davis HL, Krieg AM, Hoffman SL: Interleukin-12- and interferon γ-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun (2001) 69(3):1643-1649.
57. Freidag BL, Melton GB, Collins F, Klinman DM, Cheever A, Stobie L, Suen W, Seder RA: CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M tuberculosis. Infect Immun (2000) 68(5):2948-2953.
58. Hancock GE, Heers KM, Smith JD, Scheuer CA, Ibraghimov AR, Pryharski KS: CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV). Vaccine (2001) 19(32):4874-4882.
59. Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL: Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol (2001) 166(5):3451-3457.
60. 3 antibodies. Infect Immun (2000) 68(3):1450-1456.
61. Kawarada Y, Ganss R, Garbi N, Sacher T, Arnold B, Hammerling GJ: NK- and CD8+ T-cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides. J Immunol (2001) 167(9):5247-5253.
62. Carpentier AF, Xie J, Mokhtari K, Delattre JY: Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs. Clin Cancer Res (2000) 6(6):2469-2473.
63. Sur S, Wild JS, Choudhury BK, Sur N, Alam R, Klinman DM: Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol (1999) 162(10):6284-6293.
64. Hochreiter R, Hartl A, Freund J, Valenta R, Ferreira F, Thalhamer J: The influence of CpG motifs on a protein or DNA-based Th2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived β-galactosidase. Int Arch Allergy Immunol (2001) 124(1-3):406-410.
65. Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Spiegelberg HL, Raz E: Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol (2000) 106(1 Pt 1): 124-134.
66. Krieg AM, Wu T, Weeratna R, Efler SM, Love-Homan L, Yang L, Yi AK, Short D, Davis HL: Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA (1998) 95(21):12631-12636.
67. Zhao H, Cheng SH, Yew NS: Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs. Antisense Nucleic Acid Drug Dev (2000) 10(5):381-389.
68. Stunz LL, Lenert P, Peckham D, Yi AK, Haxhinasto S, Chang M, Krieg AM, Ashman RF: Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B-cells. Eur J Immunol (2002) 32(5):1212-1222.
69. Zhu FG, Reich CF, Pisetsky DS: Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides. J Leukocyte Biol (2002) 71(4):686-694.
70. Lenert P, Stunz L, Yi AK, Krieg AM, Ashman RF: CpG stimulation of primary mouse B-cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κB activation. Antisense Nucleic Acid Drug Dev (2001) 11(4):247-256.
71. Krieg AM, Yi AK, Hartmann G: Mechanisms and therapeutic applications of immune stimulatory CpG DNA. Pharmacol Ther (1999) 84(2):113-120.
72. Gilkeson GS, Ruiz P, Pippen AM, Alexander AL, Lefkowith JB, Pisetsky DS: Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med (1996) 183(4):1389-1397.
73. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, Kohn LD, Klinman DM: Genomic DNA released by dying cells induces the maturation of APCs. J Immunol (2001) 167(5):2602-2607.
74. Obermeier F, Dunger N, Deml L, Herfarth H, Scholmerich J, Falk W: CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur J Immunol (2002) 32(7):2084-2092.
75. Dalpke AH, Schafer MK, Frey M, Zimmermann S, Tebbe J, Weihe E, Heeg K: Immunostimulatory CpG-DNA activates murine microglia. J Immunol (2002) 168(10):4854-4863.